MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2026-03-31.

Income Overview

Net Income
-$27,816K
EPS
-$1.32
Unit: Thousand (K) dollars

Income Statement
2026-03-31
2025-12-31
Research and development
20,925 15,517*
General and administrative
8,937 2,571*
Total operating expenses
29,862 18,087
Loss from operations
-29,862 -18,087*
Interest income
2,481 391*
Other income
149 198*
Interest expense
-0*
Total other income, net
2,630 588*
Loss before income taxes
-27,232 -17,499*
Federal tax at statutory rate
-3,675*
Permanent differences
--55*
Research and development credits
--621*
Change in valuation allowance
--4,241*
Income tax benefit
0 0*
Net loss
-27,232 -17,499*
Net unrealized losses on marketable securities
-584 15
Total other comprehensive loss
-584 15*
Total comprehensive loss
-27,816 -17,484
Basic EPS
-1.32 -23.468
Diluted EPS
-1.32 -23.468
Basic Average Shares
22,704,124 744,991
Diluted Average Shares
22,704,124 744,991
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Total comprehensiveloss-$27,816K Net loss-$27,232K Total othercomprehensive loss-$584K Interest income$2,481K Other income$149K Loss before incometaxes-$27,232K Net unrealizedlosses on marketable...-$584K Total other income,net$2,630K Loss from operations-$29,862K Total operatingexpenses$29,862K Research and development$20,925K General andadministrative$8,937K

Veradermics, Inc (MANE)

Veradermics, Inc (MANE)